-
Sponsored by Gün and Partners
Selin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should be focused on R&D -
Sponsored by Wanhuida Intellectual Property
Yue Guan of Wanhuida Intellectual Property analyses a decision by the China National Intellectual Property Administration on the validity of a pulmonary hypertension drug and the implications for pharmaceutical patentees
-
Sponsored by Purplevine IP
Xiaoyan Zhou of Purplevine IP explains how the introduction of administrative measures for registering, and filing records relating to, medical devices in China should affect companies’ IP strategy
-
Sponsored by CAS
CAS explains the five high-risk areas of IP for R&D organisations and identifies how companies can protect their innovations and safeguard their growth potential
-
Sponsored by CAS
CAS shares how patent offices around the world are adopting AI, and explains the benefits of clean data, multiple algorithms, and leveraging human expertise alongside technology
-
Sponsored by CAS
The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation
-
Sponsored by CAS
Peter Blasi, business development manager at CAS IP Search, explains how to set standards for an effective IP search
-
Sponsored by CAS
Anne Marie Clark, senior patent searcher at CAS, looks at ways to protect and commercialise the promise of RNAi
-
Sponsored by CAS
CAS considers how the emerging field of RNA therapeutics highlights trends in targets, chemical modifications, and new delivery systems that increase stability of RNA
-
Sponsored by RNA Technology and IP Attorneys
Rachna Bakhru of RNA Technology and IP Attorneys discusses how companies are focused on green marketing and how brands are winning consumer trust
-
Sponsored by AJ Park
Kate Giddens of AJ Park explains the key differences between the Australian and New Zealand tests for genericism, and provides some takeaways for brand owners
-
Sponsored by Hanol IP & Law
Min Son of Hanol IP & Law explains how the Korean boy band BTS helped reshape unfair competition law and the protection of publicity rights in South Korea
